Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
University of Utah
Salt Lake City, Utah
The records below are financial disclosure and conflict of interest records obtained by ProPublica from the National Institutes of Health and dozens of large public universities across the country. The NIH only has records for researchers who seek or receive its funding.
Total Disclosures: 646. We're showing you the first 500 records. If you need every record from this institution, you can download all of our data at the ProPublica Data Store.
| Name | Type | Company | Disclosed Value | Year Filed |
|---|---|---|---|---|
| Jeremiah Alt | Conflict of Interest | Glycomira Therapeutics | $10,000-19,999 | 2012-2019 |
| R. Lor | Conflict of Interest | Daiichi Sankyo | $10,000-19,999 | 2012-2019 |
| Gerald Krueger | Conflict of Interest | Eli Lilly | $10,000-19,999 | 2012-2019 |
| Tibor Kovacsovics | Conflict of Interest | Amgen | $10,000-19,999 | 2012-2019 |
| Michael Deininger | Conflict of Interest | Novartis | $10,000-19,999 | 2012-2019 |
| Jared Thorley | Conflict of Interest | Exelixis | $10,000-19,999 | 2012-2019 |
| Howard Colman | Conflict of Interest | Hoffman La Roche/Genetech | $10,000-19,999 | 2012-2019 |
| Paul Lastayo | Conflict of Interest | N/A | $10,000-19,999 | 2012-2019 |
| Michael Deininger | Conflict of Interest | Novartis | $10,000-19,999 | 2012-2019 |
| Michael Deininger | Conflict of Interest | Novartis | $10,000-19,999 | 2012-2019 |
| Michael Deininger | Conflict of Interest | Incyte | $10,000-19,999 | 2012-2019 |
| Thomas Higgins | Conflict of Interest | Depuy Sythes | $10,000-19,999 | 2012-2019 |
| Jeremy Gililland | Conflict of Interest | DJO Surgical | $10,000-19,999 | 2012-2019 |
| Djordje Atanackovic | Conflict of Interest | Millennium Pharmaceuticals | $10,000-19,999 | 2012-2019 |
| Jutta Deininger | Conflict of Interest | Novartis | $10,000-19,999 | 2012-2019 |
| Gerald Krueger | Conflict of Interest | Janssen Pharmaceutical Inc | $10,000-19,999 | 2012-2019 |
| Michael Kay | Conflict of Interest | Navigen | $10,000-19,999 | 2012-2019 |
| Gerald Krueger | Conflict of Interest | Abbvie | $10,000-19,999 | 2012-2019 |
| Russell Butterfield | Conflict of Interest | Biogen-ldec | $10,000-19,999 | 2012-2019 |
| Gerald Krueger | Conflict of Interest | Vascular Biologies Limited | $10,000-19,999 | 2012-2019 |
| Djordje Atanackovic | Conflict of Interest | Celgene | $10,000-19,999 | 2012-2019 |
| Tibor Kovacsovics | Conflict of Interest | Amgen | $10,000-19,999 | 2012-2019 |
| Gerald Krueger | Conflict of Interest | Eli Lilly | $10,000-19,999 | 2012-2019 |
| Tibor Kovacsovics | Conflict of Interest | Celgene | $10,000-19,999 | 2012-2019 |
| Karen Ho | Conflict of Interest | Lineagen | $10,000-19,999 | 2012-2019 |
| Peter Stevens | Conflict of Interest | Orthofix, Inc | $10,000-19,999 | 2012-2019 |
| Tibor Kovacsovics | Conflict of Interest | Amgen | $10,000-19,999 | 2012-2019 |
| Gerald Krueger | Conflict of Interest | Abbvie | $10,000-19,999 | 2012-2019 |
| Christopher Pelt | Conflict of Interest | Biomet | $10,000-19,999 | 2012-2019 |
| Edward Di | Conflict of Interest | N/A | $10,000-19,999 | 2012-2019 |
| Frederick Welt | Conflict of Interest | Medtronic | $10,000-19,999 | 2012-2019 |
| Tibor Kovacsovics | Conflict of Interest | Celgene | $10,000-19,999 | 2012-2019 |
| Michael Deininger | Conflict of Interest | Incyte | $10,000-19,999 | 2012-2019 |
| Robert Tashjian | Conflict of Interest | Wright Medical Technology | $10,000-19,999 | 2012-2019 |
| Gerald Krueger | Conflict of Interest | Abbvie | $10,000-19,999 | 2012-2019 |
| Meghan Zorn | Conflict of Interest | Teva | $5,000-9,999 | 2012-2019 |
| Douglas Sborov | Conflict of Interest | Celgene | $5,000-9,999 | 2012-2019 |
| Leslie Jerominski | Conflict of Interest | Janssen Pharmaceutical Inc | $5,000-9,999 | 2012-2019 |
| Howard Colman | Conflict of Interest | Hoffman La Roche/Genetech | $5,000-9,999 | 2012-2019 |
| Sancy Leachman | Conflict of Interest | Myriad Genetics | $5,000-9,999 | 2012-2019 |
| Gerald Gleich | Conflict of Interest | GlaxoSmithKline | $5,000-9,999 | 2012-2019 |
| Michael Deininger | Conflict of Interest | Ariad | $5,000-9,999 | 2012-2019 |
| Sancy Leachman | Conflict of Interest | Myriad Genetics | $5,000-9,999 | 2012-2019 |
| Harry Hill | Conflict of Interest | Vidara Therapeutics | $5,000-9,999 | 2012-2019 |
| Howard Colman | Conflict of Interest | Hoffman La Roche/Genetech | $5,000-9,999 | 2012-2019 |
| Joel Cooper | Conflict of Interest | Red Scientific | $5,000-9,999 | 2012-2019 |
| Edward Dudek | Conflict of Interest | Rugen | $5,000-9,999 | 2012-2019 |
| Djordje Atanackovic | Conflict of Interest | Amgen/Onyx | $5,000-9,999 | 2012-2019 |
| Gerald Krueger | Conflict of Interest | Novartis | $5,000-9,999 | 2012-2019 |
| Djordje Atanackovic | Conflict of Interest | Bristol-Myers Squibb | $5,000-9,999 | 2012-2019 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.